ResearcherShenyang Pharmaceutical UniversityActive in the last 2 years

Gang Cheng

Verified by OpenAlex author ID (good confidence)As of 10 November 2026

Matched on OpenAlex author ID A5108401441.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Corrigendum to "Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analys… Last author DOI 10.1016/j.clinthera.2024.11.010 ↗
Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized… Last author DOI 10.1016/j.clinthera.2024.06.015 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Adili Tuersun · 2 shared papers, 2024–2025
- Paper Corrigendum to "Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptid… DOI 10.1016/j.clinthera.2024.11.010 ↗
- Paper Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors… DOI 10.1016/j.clinthera.2024.06.015 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.